User enablement is an essential component of an outstanding user experience. At Luminex, we take usability a step further by equipping our customers with the knowledge and training they need in order to get the most from our products.
The Faces of Luminex: Curtis Ford, Engineering
It might not be rocket science, but former aerospace engineer Curtis Ford shares how his background across two important fields in engineering led to his career here, where he helps oversee the quality of Luminex products.
COVID-19 and Characterizing the Immune Response: A Method for Isotyping Using xMAP® Technology
While early measurements of COVID-19 patients’ antibodies against SARS-CoV-2 focused on the IgG isotype, IgA and IgM responses are also important for fully understanding the body’s immune response to COVID-19.
The Faces of Luminex: Brett Osburn, Manufacturing
Here at Luminex, we’re proud to design and manufacture the products we sell—whether we’re synthesizing dyes fo…
Five xMAP® Technology Tips from Luminex Tech Support
Whether you’re a new or experienced xMAP Technology user, our Technical Support Team can help you! They’ve compiled five tips based on questions that users frequently ask.
Will Molecular Diagnostics Work with the New COVID-19 Variants?
Virus mutations are common and SARS-CoV-2 is no exception. As new variants have begun emerging, the focus around COVID-19 has shifted to these new mutations as scientists work to understand if they will be covered by existing tests and vaccines.
How COVID-19 Is Changing Respiratory Testing Algorithms
Clinical algorithms used for respiratory tests continue to evolve, especially after accommodating the continuous presence of COVID-19 for more than a year now.
Crucial Guidance for Testing and Treating COVID-19 Patients: How the IDSA is Putting Patients and Healthcare Workers First
As the pandemic has progressed, research and medical approaches have rapidly evolved, shifting our understanding of how various therapies work for multiple levels of illness severity. The IDSA’s treatment recommendations are listed in a table that provides specific guidance on various therapies, along with a graded level of certainty for each recommendation based on clinical evidence.
Multiplex Technology Optimizes Traditional Immunogenicity Testing
In a recent study, researchers used xMAP® Technology to design a multiplex assay from two separate immunogenicity assays to simultaneously identify and isotype ADAs in humans who received Humira®, a TNF inhibitor with a well-documented immunogenicity profile that is commonly used to treat rheumatoid arthritis and other inflammatory disorders.
The Faces of Luminex: Aaron Benfield, Molecular Applications
For labs that perform molecular diagnostic testing, implementing new products can occasionally require trainin…